Treatment of Erythromycin and Cisapride for Neonates with Feeding Intolerance

黄瑛,邵肖梅,曾纪骅,赵瑞芳,季志英,袁红
DOI: https://doi.org/10.3969/j.issn.1672-8467.2001.05.015
2001-01-01
Abstract:Purpose: To investigate the effects of erythromycin and cisapride promoting neonatal gastrointestinal motility and improving neonatal feeding. Methods: During the year of Nov. 1997 to Feb. 1999,41 hospitalized neonates which were suffered from feeding problems were studied. Erythromycin (3-5)mg/(kg·d) by intravenous infusion and 0.1% solution of cisapride (0.2-0.3)ml/kg, three times a day by oral were used in our study. Gastroesophageal scintigraphy and radioimmuno assay were measured before and after the intervention. Results: 27 neonates were treated with erythromycin for (7.8 ± 2.2) d, after that GE60% was increased from (22.9 ± 12.6)% to (38.7+17.1)%, RI was decreased from 16.9 ± 9.4 to 8.1 ± 5.7, P < 0. 001; plasma motilin was incerased significantly [from (583.2 ± 253.1) to (907.5 ± 301.1)pg/ml, P < 0.001] but senan gastrin didn't change greatly [(52.8 ± 12.9) vs (58.7 ± 20.4)pg/ml, P > 0.05].14 neonates took cisapride for (9.4 ± 2.2) d, GE60% was increased from (26.2 ± 14.7)% to (40.0 ± 17.4)%, RI was decreased from 17.3 ± 11.4 to 7.2 ± 3.5, (P < 0.01). But blood leve] of gastrin and motilin didn't change significantly. After treatment, there was no difference of the volume of milk taken between the two groups (176.2 ± 49.4)ml/(kg·d) in erythromycin group and (197.5 ± 35.8) ml/(kg·d) in cisapride group, (P > 0.05). There were no obvious side effects of the two drugs in this study. Conclusions: Erythromycin and cisapride can promote neonatal gastrointestinal motility and improve their feeding. How to choose these drugs depends on the specific situations.
What problem does this paper attempt to address?